These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12527665)

  • 1. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial.
    Fitchet A; Doherty PJ; Bundy C; Bell W; Fitzpatrick AP; Garratt CJ
    Heart; 2003 Feb; 89(2):155-60. PubMed ID: 12527665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive cardiac rehabilitation improves outcome for patients with implantable cardioverter defibrillator. Findings from the COPE-ICD randomised clinical trial.
    Berg SK; Pedersen PU; Zwisler AD; Winkel P; Gluud C; Pedersen BD; Svendsen JH
    Eur J Cardiovasc Nurs; 2015 Feb; 14(1):34-44. PubMed ID: 24504872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillator specific rehabilitation improves health cost outcomes: Findings from the COPE-ICD randomized controlled trial.
    Berg SK; Zwisler AD; Koch MB; Svendsen JH; Christensen AV; Pedersen PU; Thygesen LC
    J Rehabil Med; 2015 Mar; 47(3):267-72. PubMed ID: 25437827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation.
    Isaksen K; Morken IM; Munk PS; Larsen AI
    Eur J Prev Cardiol; 2012 Aug; 19(4):804-12. PubMed ID: 22988593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aerobic interval training on measures of anxiety, depression and quality of life in patients with ischaemic heart failure and an implantable cardioverter defibrillator: A prospective non-randomized trial.
    Isaksen K; Munk PS; Giske R; Larsen AI
    J Rehabil Med; 2016 Mar; 48(3):300-6. PubMed ID: 26667151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of early comprehensive cardiac rehabilitation following the implantation of cardioverter-defibrillator.
    Śmiałek J; Lelakowski J; Majewski J
    Kardiol Pol; 2013; 71(10):1021-8. PubMed ID: 24197582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions.
    Lewin RJ; Coulton S; Frizelle DJ; Kaye G; Cox H
    Heart; 2009 Jan; 95(1):63-9. PubMed ID: 18070951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Effects and Implications of Cardiac Rehabilitation for Implantable Cardioverter Defibrillator Patients: A Mixed-Methods Approach Embedding Data From the Copenhagen Outpatient ProgrammE-Implantable Cardioverter Defibrillator Randomized Clinical Trial With Qualitative Data.
    Berg SK; Moons P; Christensen AV; Zwisler AD; Pedersen BD; Pedersen PU
    J Cardiovasc Nurs; 2015; 30(5):420-7. PubMed ID: 25055078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients.
    van den Broek KC; Nyklícek I; van der Voort PH; Alings M; Meijer A; Denollet J
    J Am Coll Cardiol; 2009 Aug; 54(6):531-7. PubMed ID: 19643315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerobic interval training in patients with heart failure and an implantable cardioverter defibrillator: a controlled study evaluating feasibility and effect.
    Isaksen K; Munk PS; Valborgland T; Larsen AI
    Eur J Prev Cardiol; 2015 Mar; 22(3):296-303. PubMed ID: 24403295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator.
    Afzal MR; Evenson C; Badin A; Patel D; Godara H; Essandoh M; Okabe T; Tyler J; Houmsse M; Augostini R; Hummel J; Kalbfleisch S; Daoud EG; Weiss R
    Heart Rhythm; 2017 Oct; 14(10):1436-1439. PubMed ID: 28624663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical activity in primary versus secondary prevention indication implantable cardioverter defibrillator recipients 6-12 months after implantation - a cross-sectional study with register follow up.
    Berg SK; Thygesen LC; Svendsen JH; Christensen AV; Zwisler AD
    Arch Phys Med Rehabil; 2015 Mar; 96(3):426-31. PubMed ID: 25448249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial.
    Sears SF; Rosman L; Sasaki S; Kondo Y; Sterns LD; Schloss EJ; Kurita T; Meijer A; Raijmakers J; Gerritse B; Auricchio A
    Heart Rhythm; 2018 May; 15(5):734-740. PubMed ID: 29277687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phantom shocks in patients with implantable cardioverter defibrillator: results from a randomized rehabilitation trial (COPE-ICD).
    Berg SK; Moons P; Zwisler AD; Winkel P; Pedersen BD; Pedersen PU; Svendsen JH
    Europace; 2013 Oct; 15(10):1463-7. PubMed ID: 23599170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cardiac rehabilitation in patients with ICD: are gender differences present? Results from the COPE-ICD trial.
    Christensen AV; Zwisler AD; Svendsen JH; Pedersen PU; Blunk L; Thygesen LC; Berg SK
    Pacing Clin Electrophysiol; 2015 Jan; 38(1):18-27. PubMed ID: 25224097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators.
    DeMaso DR; Lauretti A; Spieth L; van der Feen JR; Jay KS; Gauvreau K; Walsh EP; Berul CI
    Am J Cardiol; 2004 Mar; 93(5):582-7. PubMed ID: 14996583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator.
    Cho EN; von Känel R; Marten-Mittag B; Ronel J; Kolb C; Baumert J; Ladwig KH
    Heart; 2012 May; 98(10):806-12. PubMed ID: 22543838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Web-based distress management for implantable cardioverter defibrillator patients: A randomized controlled trial.
    Habibović M; Denollet J; Cuijpers P; van der Voort PH; Herrman JP; Bouwels L; Valk SD; Alings M; Theuns DA; Pedersen SS
    Health Psychol; 2017 Apr; 36(4):392-401. PubMed ID: 28192003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.